FDA’s Prasad Vows to Make Rare Disease Drugs Available at ‘First Sign of Promise’

The FDA plans to “rapidly make available” rare disease drugs and make use of surrogate endpoints to get promising medicines to patients before they clear the traditional efficacy bar for authorization, Prasad said Tuesday.